Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bloch

Showing results (41-50 of 672) with videos related to

Pageof 68
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|August 3, 2007
Defining the role of angiotensin receptor blocker therapy in Japanese persons with underlying vascular disease: the Jikei Heart StudyMichael J Bloch, Jan Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|May 12, 2006
Analysis of recent papers in hypertension: differences in central aortic blood pressure explain outcome differences in ASCOT: the CAFE substudy; and rimonabant improves multiple cardiometabolic parameters in overweight and obese individualsMichael J Bloch, Jan Basile
Rheumatology|January 1, 1970
Mast cells and mast cell-sensitizing (homocytotropic) antibodiesK J Bloch, C Angevine
Seminars in Nephrology|October 7, 2000
Renal vascular disease: medical management, angioplasty, and stentingM J Bloch, T Pickering
Journal of Clinical Hypertension (Greenwich, Conn.)|June 27, 2003
The diagnosis and management of renovascular disease: a primary care perspective. Part I. Making the diagnosisMichael J Bloch, Jan Basile
Minerva Medica|October 7, 2004
Clinical insights into the diagnosis and management of renovascular disease. An evidence-based reviewM J Bloch, J Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|March 7, 2008
Cholesterol ester transfer protein inhibition with torcetrapib leads to an increase in cardiovascular events: an effect that is unlikely to be the result of increases in blood pressure aloneMichael J Bloch, Jan Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|March 29, 2008
Chronotherapy in patients with chronic kidney disease to reduce nighttime blood pressure--not ready for prime timeMichael J Bloch, Jan Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|July 20, 2006
Analysis of recent papers in hypertensionMichael J Bloch, Jan Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|February 23, 2007
Hypertension prevalence increases and hypertension control rates improve in the United States: 2003-2004Michael J Bloch, Jan Basile
Pageof 68

Showing results (41-50 of 672) with videos related to

Sort By:
Pageof 68
Journal of Clinical Hypertension (Greenwich, Conn.)|August 3, 2007
Defining the role of angiotensin receptor blocker therapy in Japanese persons with underlying vascular disease: the Jikei Heart StudyMichael J Bloch, Jan Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|May 12, 2006
Analysis of recent papers in hypertension: differences in central aortic blood pressure explain outcome differences in ASCOT: the CAFE substudy; and rimonabant improves multiple cardiometabolic parameters in overweight and obese individualsMichael J Bloch, Jan Basile
Rheumatology|January 1, 1970
Mast cells and mast cell-sensitizing (homocytotropic) antibodiesK J Bloch, C Angevine
Seminars in Nephrology|October 7, 2000
Renal vascular disease: medical management, angioplasty, and stentingM J Bloch, T Pickering
Journal of Clinical Hypertension (Greenwich, Conn.)|June 27, 2003
The diagnosis and management of renovascular disease: a primary care perspective. Part I. Making the diagnosisMichael J Bloch, Jan Basile
Minerva Medica|October 7, 2004
Clinical insights into the diagnosis and management of renovascular disease. An evidence-based reviewM J Bloch, J Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|March 7, 2008
Cholesterol ester transfer protein inhibition with torcetrapib leads to an increase in cardiovascular events: an effect that is unlikely to be the result of increases in blood pressure aloneMichael J Bloch, Jan Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|March 29, 2008
Chronotherapy in patients with chronic kidney disease to reduce nighttime blood pressure--not ready for prime timeMichael J Bloch, Jan Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|July 20, 2006
Analysis of recent papers in hypertensionMichael J Bloch, Jan Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|February 23, 2007
Hypertension prevalence increases and hypertension control rates improve in the United States: 2003-2004Michael J Bloch, Jan Basile
Pageof 68